# The Effect of Nebulization of Alkaline Solution on Treating XDRAB Pneumonia With C/S Plus Minocycline

> **NCT02060149** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Xijing Hospital** · enrollment: 90 (estimated)

## Conditions studied

- Pneumonia

## Interventions

- **DRUG:** C/S plus minocycline.
- **DRUG:** nebulization with pH 7.4 solution
- **DRUG:** nebulization with pH 7.8 solution
- **DRUG:** No nebulization

## Key facts

- **NCT ID:** NCT02060149
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-03
- **Primary completion:** 2015-03
- **Final completion:** 2015-04
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2014-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02060149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02060149, "The Effect of Nebulization of Alkaline Solution on Treating XDRAB Pneumonia With C/S Plus Minocycline". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02060149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*